GlassScriptPhysician profile
Christopher J Lobo
NPI 1225049307
$257.20
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $14.90.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $54.63 | 2019 | |
| Therapeuticsmd, INC. | $41.83 | 2019 | |
| Abbvie INC. | $39.62 | 2019 | |
| Roche Diagnostics Corporation | $21.21 | 2019 | |
| Allergan, INC. | $17.79 | 2019 | |
| Duchesnay USA Incorporated | $17.03 | 2019 | |
| Avion Pharmaceuticals | $14.90 | 2020 | |
| Amag Pharmaceuticals, INC. | $13.56 | 2019 | |
| Mylan Pharmaceuticals INC. | $13.34 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.78 | 2019 | |
| Merck Sharp & Dohme LLC | $11.51 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Lobo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.